This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08396/identifier/pdb/
n12http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB08396/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08396/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08396/identifier/drugbank/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08396/identifier/chemspider/

Statements

Subject Item
n2:DB08396
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB08396 n12:DB08396
dcterms:title
4-{[(Z)-(5-OXO-2-PHENYL-1,3-OXAZOL-4(5H)-YLIDENE)METHYL]AMINO}BUTANOIC ACID
adms:identifier
n9:99444867 n10:PHX n11:46937146 n13:22378005 n14:DB08396
n5:IUPAC-Name
n6:271B5419-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B541F-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B541E-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B541B-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B541C-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B541D-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5417-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5415-363D-11E5-9242-09173F13E4C5 n6:271B5418-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5416-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5425-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5426-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5420-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5421-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5423-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5422-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5424-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B542B-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B542D-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B542E-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B542A-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5429-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B542C-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B541A-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5427-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5428-363D-11E5-9242-09173F13E4C5